MAVEN INCOME AND GROWTH VCT 3 PLC

Delisting Announcement • Dec 18, 2019

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 2094X

Official List

18 December 2019

NOTICE OF TEMPORARY SUSPENSION OF LISTING FROM THE OFFICIAL LIST
18/12/2019 07:30
TEMPORARY SUSPENSION
Maven Income and Growth VCT 6 PLC
The Financial Conduct Authority ("the FCA") temporarily suspends the securities set out below from the Official List effective from 18/12/2019 07:30 at the request of the company :

Security Description	Listing Category	ISIN
Ordinary shares of 10p each; fully paid	Premium Equity Closed Ended Investment Funds	GB00B1BV3Z44 ●

This notice has been issued by Issuer Management - 020 7066 8352.

Notes

SEDOL numbers which are allocated by the London Stock Exchange as a Stock Exchange identifier may be found on their dealing notice.

●Denotes the security is being admitted to trading on the London Stock Exchange, a Recognised Investment Exchange.

†Denotes the security is also being admitted to trading on NEX Exchange, a Recognised Investment Exchange.

Denotes the security is also being admitted to trading on Euronext, a Recognised Investment Exchange.

∼Denotes the security is also being admitted to trading on Cboe Europe, a Recognised Investment Exchange.

^Denotes the security is also being admitted to trading on Shanghai-London Stock Connect, a Recognised Investment Exchange.

Notices issued by the FCA in respect of admission of securities to the Official List must be read in conjunction with notices issued by the relevant Recognised Investment Exchange in respect of admission of securities to trading on its markets.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

SUSEALAXFSPNFFF